ICOS and hepatocellular carcinoma: HepG2 cells were used in the current study with RNAi technology to knockdown the expression of the ICOS gene of co-stimulatory molecules in hepatoma cells, and to analyze the cell proliferation and invasion capacities of HepG2 cells after ICOS gene knockdown.